Home|Journals|Articles by Year

Directory for Medical Articles

Original Article

The Effect of Darapladib Therapy for the Expression of Lp-PLA2 in Dyslipidemia and Type 2 Diabetes Mellitus Atherosclerosis Model

Titin Andri Wihastuti, Rosaria Dian Lestari, Teuku Heriansyah.


Lipoprotein associated phospholipase A2 (Lp-PLA2) activity is suspected to contribute in atherosclerosis development. This study investigated the role of Lp-PLA2 and Lp-PLA2 selective inhibitor (darapladib) in atherogenesis. Conclucively, Darapladib significantly decreased Lp-PLA2 protein but was shown to increase the Lp-PLA2 mRNA levels in blood and aortic tissue in dyslipidemia and type 2 DM model.

Key words: darapladib, dyslipidemia, atherosclerosis, T2DM, Lp-PLA2, LP-PLA2 inhibitor

Full-text options

Share this Article

Online Article Submission
• ejmanager.com
• ojshosting.net

Do you want to use OJS for your journal ?
work with an experienced partner

Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.